Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Identification of a novel anti-sigmaE factor in Neisseria meningitidis.

Hopman CT, Speijer D, van der Ende A, Pannekoek Y.

BMC Microbiol. 2010 Jun 4;10:164. doi: 10.1186/1471-2180-10-164.

2.

Complement factor 7 gene mutations in relation to meningococcal infection and clinical recurrence of meningococcal disease.

Kuijpers TW, Nguyen M, Hopman CT, Nieuwenhuys E, Dewald G, Lankester AC, Roos A, van der Ende A, Fijen C, de Boer M.

Mol Immunol. 2010 Jan;47(4):671-7. doi: 10.1016/j.molimm.2009.10.017. Epub 2009 Nov 22.

PMID:
19931914
3.

Molecular characterization and identification of proteins regulated by Hfq in Neisseria meningitidis.

Pannekoek Y, Huis in 't Veld R, Hopman CT, Langerak AA, Speijer D, van der Ende A.

FEMS Microbiol Lett. 2009 May;294(2):216-24. doi: 10.1111/j.1574-6968.2009.01568.x. Epub 2009 Apr 3.

4.

Outbreak of meningococcal disease caused by PorA-deficient meningococci.

van der Ende A, Hopman CT, Keijzers WC, Spanjaard L, Lodder EB, van Keulen PH, Dankert J.

J Infect Dis. 2003 Mar 1;187(5):869-71. Epub 2003 Feb 18.

PMID:
12599063
5.

In vivo expression of Neisseria meningitidis proteins homologous to the Haemophilus influenzae Hap and Hia autotransporters.

van Ulsen P, van Alphen L, Hopman CT, van der Ende A, Tommassen J.

FEMS Immunol Med Microbiol. 2001 Dec;32(1):53-64.

6.

Multiple mechanisms of phase variation of PorA in Neisseria meningitidis.

van der Ende A, Hopman CT, Dankert J.

Infect Immun. 2000 Dec;68(12):6685-90.

7.
8.

Comparison of commercial diagnostic tests for identification of serogroup antigens of Neisseria meningitidis.

van der Ende A, Schuurman IG, Hopman CT, Fijen CA, Dankert J.

J Clin Microbiol. 1995 Dec;33(12):3326-7.

9.
12.
14.

Comparison of meningococcal outer membrane protein vaccines solubilized with detergent or C polysaccharide.

Poolman JT, Timmermans HA, Hopman CT, Teerlink T, Van Vught PA, Witvliet MH, Beuvery EC.

Antonie Van Leeuwenhoek. 1987;53(6):413-9.

PMID:
3130780
15.

Class 1/3 outer membrane protein vaccine against group B, type 15, subtype 16 meningococci.

Poolman JT, Beuvery EC, Hopman CT, Witvliet MH, Timmermans HA, Teerlink T, Zanen HC.

Dev Biol Stand. 1986;63:147-52.

PMID:
3091433
16.
17.

Immunogenicity of meningococcal antigens as detected in patient sera.

Poolman JT, Hopman CT, Zanen HC.

Infect Immun. 1983 Apr;40(1):398-406.

Supplemental Content

Loading ...
Support Center